Hepatitis b Trials in Beijing, China
Conditions / Hepatitis b / Beijing, China
Hepatitis b has been the subject of sustained clinical investigation across multiple research sites.
27 total trials for this combination
Showing top 10 of 27 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03020745 | A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects | COMPLETED | PHASE2 |
| NCT06537414 | A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04449029 | A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) | COMPLETED | PHASE2 |
| NCT04676724 | Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) | COMPLETED | PHASE2 |
| NCT01163240 | Epidemiological Study in Children and Adolescents With Chronic Hepatitis B | COMPLETED | — |
| NCT03361956 | An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection | COMPLETED | PHASE2 |
| NCT01962155 | Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters | COMPLETED | — |
| NCT06379334 | Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population | ACTIVE_NOT_RECRUITING | — |
| NCT02108444 | Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients | COMPLETED | — |
| NCT02849132 | Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients | UNKNOWN | PHASE4 |